§2. Civil right of action related to gender-related medical treatment
This section establishes a federal civil right of action allowing any individual on whom gender-related medical treatment (i.e., gender-affirming care) was performed while a minor to sue each person who performed the treatment in U.S. district court for actual damages or liquidated damages of $250,000 per instance, plus costs including reasonable attorney's fees. Suits may be brought by the individual or, if under 18, incompetent, incapacitated, or deceased, by a legal guardian, estate representative, family member, or court-appointed person; jurisdiction requires a nexus to interstate or foreign commerce (e.g., travel, payments, communications, instruments used, or conduct affecting commerce).
The section defines "gender-related medical treatment" for female individuals as treatments to affirm a perceived non-female gender or sex—including specified surgeries (e.g., phalloplasty, subcutaneous mastectomy), exogenous testosterone, and puberty blockers (e.g., GnRH agonists)—and analogously for male individuals (e.g., vaginoplasty, exogenous estrogen); it excludes treatments for disorders of sex development (diagnosed via genetic/biochemical testing), irresolvably ambiguous sex characteristics (e.g., 46 XX with virilization), or infections/injuries caused by prior such treatment. It further defines "sex" as the biological determination of male or female.